(Q43638610)

25 November 2017

title

Functional interactions between endocannabinoid and CCK neurotransmitter systems may be critical for extinction learning (English)

1 reference

25 November 2017

main subject

endocannabinoid system

0 references

1 reference

7

1 reference

25 November 2017

Jasmeer P Chhatwal

1

1 reference

25 November 2017

Alisa R Gutman

2

1 reference

25 November 2017

Kimberly A Maguschak

3

1 reference

25 November 2017

Michael E Bowser

4

1 reference

25 November 2017

Yong Yang

5

1 reference

25 November 2017

Michael Davis

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

25 June 2008

1 reference

25 November 2017

published in

Neuropsychopharmacology

1 reference

25 November 2017

volume

34

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

509-521

1 reference

A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Asymmetry in behavioral responses to cholecystokinin microinjected into rat nucleus accumbens and amygdala.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Influence of ethanol withdrawal on fear memory: Effect of D-cycloserine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Amygdala BDNF signaling is required for consolidation but not encoding of extinction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Lack of effect of CCKB receptor antagonists in ethological and conditioned animal screens for anxiolytic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Intracerebroventricular infusion of the CCKB receptor agonist pentagastrin potentiates acoustic startle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Endocannabinoids in the central nervous system: from neuronal networks to behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

CCK in animal and human research on anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Effect of the selective CCKB receptor antagonist LY288513 on conditioned fear stress in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

The CCKB antagonist, L-365,260, attenuates fear-potentiated startle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Effects of D-cycloserine on extinction of conditioned freezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

The endogenous cannabinoid system controls extinction of aversive memories

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

The effect of CB(1) receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Memory reconsolidation and extinction have distinct temporal and biochemical signatures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

A spatial map of olfactory receptor expression in the Drosophila antenna.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

Facilitation of conditioned fear extinction by d-cycloserine is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase cascades and requires de novo protein synthesis in basolateral nucleus of amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

The design and calibration of a startle measurement system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

7 January 2021

Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

7 January 2021

A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

7 January 2021

The role of ventromedial prefrontal cortex in the recovery of extinguished fear

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

7 January 2021

Regulation of synaptic plasticity genes during consolidation of fear conditioning

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

7 January 2021

Consolidation of extinction learning involves transfer from NMDA-independent to NMDA-dependent memory.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

7 January 2021

Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.97

7 January 2021

Identifiers

DOI

10.1038/NPP.2008.97

1 reference

Dimensions Publication ID

25 November 2017

1009224363

0 references

1 reference